supply of essential medicines (drugs) to cms/different esi hospitals under esi (mb) scheme, w.b. , acalabrutinib 100 mg , acetic acid otic solution 2% (10ml) , acetylcysteine 200mg/ml inj (5 ml) , ademetionine 400 mgtab/cap , adrenaline 1mg/ml inj (1ml) , ahf ( recombinant) glycopegylated -exei 500 iu inj , recombinant anti hemophillic factor viii (ahf) 250 iu inj , recombinant anti hemophillic factor viii (ahf) 500 iu inj , recombinant anti hemophillic factor viii (ahf) 1000 iu inj , human recombinant coagulation factor vii 1 mg inj , human recombinant coagulation factor vii 2 mg inj , alprostadil 500 mcg/ml inj (1 ml) , ambrisentan 5 mg tab/cap , ascorbic acid 500 mg chewable tab , bcg vaccine 40 mg inj , benzyl nicotinate (2 mg) + heparin (50 iu)20 gm tube , bisacodyl 5 mg tab , bleomycin 15 mg inj , glycopyrrolate 0.2 mg/ml inj (1ml) , glycopyrrolate 0.2 mg/ml inj (5ml) , botulinum toxin type-a 50 unit for human use inj , bromphenac eye drop 0.09% w/v (5ml) , buprenorphine trans dermal patch 10 mcg/hour (pack of 2patches) , butorphanol 2 mg/ml inj (1ml) , calcium acetate 667 mg tab , capd fluid 1.5 % 2 lt , capd fluid 2.5 % 2 lt , calcitriol 0.25 mcg tab/cap , carbacol 0.01% w/v intraoccular solution (1ml) , carbetocin 100 mcg/ml inj (1ml) , carbozantinib 20 mg tab , celecoxib 200 mg tab , cerebroproteinhydrolysate 60 mg inj , ceritinib 150 mg tab , chlorhexidine 1.5% and cetrimide 3%lotion (500 ml) , chloroform spirit (500ml) for use in medical field , chloroquine phosphate 250 mg tab , citicoline 500 mg + piracetam 400 mgtab , clindamycin 300 mg inj , clonazepam 0.25 mg tab , clonazepam 0.5 mg + escitalopram 10 mg tab , clonidine hydrochloride 150 mcg/ml inj (1 ml) , codeine phosphate linctus syrup 10 mg/5ml (100ml) , cyclopentolate eye drop 1% w/v (5ml) , cyclophosphamide 50 mg tab , dacarbazine 200 mg inj , dapagliflozin 5 mg tab , daptomycin 350 mg inj , dexamethasone 4 mg tab , doripenem 500 mg inj , eltrombopag 50 mg tab/cap , erythropoetin 6000 iu inj ,